John Dobak is the founder of DermTech International. DermTech International has raised $16M in total funding. Latest round: Series B.
John Dobak is an executive at DermTech, which develops non-invasive genomic tests using adhesive patches to collect skin samples for the detection of melanoma and other skin cancers. The company went public in September 2019 via a SPAC merger, raising $143 million and reaching a peak valuation of $1 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide